Indobufen

In today's world, Indobufen has become a topic of great relevance and interest to a wide spectrum of people. From its impact on society to its relevance in the scientific field, Indobufen is a phenomenon that leaves no one indifferent. Throughout history, Indobufen has been the subject of numerous debates and has generated all kinds of opinions and theories. In this article, we will explore the different facets of Indobufen, analyzing its implications and its influence on different aspects of our daily lives.

Chemical compound

Pharmaceutical compound

Indobufen

Clinical data
AHFS/Drugs.com	International Drug Names
ATC code	B01AC10 (WHO)
Identifiers
IUPAC name 2-(4-(1-Oxoisoindolin-2-yl)phenyl)butanoic acid
CAS Number	63610-08-2 Y
PubChem CID	107641
ChemSpider	96823 N
UNII	6T9949G4LZ
KEGG	D07141 Y
ChEMBL	ChEMBL1765292 N
CompTox Dashboard (EPA)	DTXSID7057789
ECHA InfoCard	100.058.496
Chemical and physical data
Formula	C18H17NO3
Molar mass	295.338 g·mol−1
3D model (JSmol)	Interactive image
SMILES O=C(O)C(c1ccc(cc1)N3C(=O)c2ccccc2C3)CC
InChI InChI=1S/C18H17NO3/c1-2-15(18(21)22)12-7-9-14(10-8-12)19-11-13-5-3-4-6-16(13)17(19)20/h3-10,15H,2,11H2,1H3,(H,21,22) N Key:AYDXAULLCROVIT-UHFFFAOYSA-N N
NY (what is this?)  (verify)

Indobufen is a platelet aggregation inhibitor.^[1] It acts as a reversible cyclooxygenase inhibitor.^[2]

References

1. ^ The Merck Index (12th ed.). p. 4991.
2. ^ Eligini S, Violi F, Banfi C, Barbieri SS, Brambilla M, Saliola M, et al. (January 2006). "Indobufen inhibits tissue factor in human monocytes through a thromboxane-mediated mechanism". Cardiovascular Research. 69 (1): 218–26. doi:10.1016/j.cardiores.2005.07.013. PMID 16154551.

This drug article relating to the blood and blood forming organs is a stub. You can help Wikipedia by expanding it.

• v
• t
• e